Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
about
Cardiac MR imaging: current status and future direction.Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologiesMyocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mappingAdvances in parametric mapping with CMR imagingMyocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation.Cardiac sarcoidosis: case report, workup, and review of the literature.Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical TrialCardiovascular Computed Tomography and Magnetic Resonance: History and Growing Impact in Brazil and in the WorldT1 mapping and survival in systemic light-chain amyloidosis.Cardiovascular magnetic resonance for amyloidosis.Prospective, randomized comparison of gadopentetate and gadobutrol to assess chronic myocardial infarction applying cardiovascular magnetic resonance.Increased myocardial extracellular volume in active idiopathic systemic capillary leak syndromeDiagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis.Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.Cardiovascular Magnetic Resonance Visualization of Cardiac Amyloid Infiltration: Challenges and Opportunities.Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials.Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapyMyocardial tissue remodeling in adolescent obesityMyocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.Myocardial T1 and T2 Mapping: Techniques and Clinical Applications.Myocardial T1 mapping: modalities and clinical applications.Novel strategies for the diagnosis and treatment of cardiac amyloidosis.Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.Use of Noninvasive Imaging in Cardiac Amyloidosis.Recent advances in the noninvasive strategies of cardiac amyloidosis.T1 mapping: characterisation of myocardial interstitial space.Role of Imaging in Evaluating Infiltrative Heart Disease.Recent Advances in Cardiovascular Magnetic Resonance: Techniques and Applications.Accurate analysis and visualization of cardiac (11)C-PIB uptake in amyloidosis with semiautomatic software.How to image cardiac amyloidosis.The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy.Variability of cardiovascular magnetic resonance (CMR) T1 mapping parameters in healthy volunteers during long-term follow-up.Quantitative molecular imaging of cardiac amyloidosis: The journey has begun.Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis
P2860
Q26786658-65E08245-5F02-4D8D-838F-DC614E9BF068Q26824231-F0D80BC7-1826-4494-B535-36253CDC2D9DQ27025677-7179BC18-CC3F-481F-980F-D59986F82819Q30412201-51D9BC51-B057-496B-B1A1-95D1D4A3DD4DQ30421950-337A8F58-5521-408A-AF26-F87F50D106C6Q30434303-618508B3-B843-49DE-B1AF-D3DB69216830Q34392552-899A95C2-50EA-44B3-957A-0C7D662B09A1Q34536010-9C8AE4C1-3652-4F5E-9993-2EABD06DEC6FQ34669951-3953F7A8-58BB-42E1-A4C3-2C867385466BQ34994098-87111B8E-E144-4845-B678-5EAACEA32932Q35535955-24C83B71-2951-43A9-8ADC-54F1D58AF91CQ35844039-5734FFF6-8475-4A1E-AACA-3189356A141FQ36000241-7966896D-EF30-4B66-AE1F-6B68ACBA5782Q36042226-259D6CE5-7A1C-4ACD-9473-A82CDE15D2E0Q36165179-EADCC82A-D01A-4BA9-9A3C-53CE753CC49DQ36497212-48A66906-2B22-4651-A3D1-D303A58B8739Q36555925-B43FE417-28FE-476D-9BED-27A98CF25EB5Q36625503-1A98A00A-7F41-4AB1-9620-3B51B38B0F95Q37310497-6A12B599-7B47-4BC9-9EC3-4A675BF39ED3Q37371632-4488C171-FF78-49CD-85FF-4C7EDF05F491Q37589574-BDCC18CC-8C3F-48BE-86C7-64D36D239494Q37717684-4B2B9EEC-B664-41D6-8F4C-7A095944E9D0Q38614967-4B46D277-2B8F-46A8-86E3-B43C18030ECCQ38663987-38337762-C3ED-4A4B-9E5E-1733143AB34BQ38834998-A1726832-92CB-4450-8EAD-FC3DD62B2CCFQ38935425-D3E5B091-D0D9-4301-91F8-A25FDE3E297BQ39094183-E6A33F93-48DC-4629-967D-7877ADC0F9B1Q39114674-6CA92635-6F2A-4973-A621-DFFFE504DA82Q39370604-D6CCACB2-A33F-404A-8EF3-C678E8822596Q40737924-9967011D-E5D4-41EE-AF73-8CB458DA2974Q41867190-0D26BB21-23D5-4198-8C92-206B4D295226Q47098908-F0AB24DE-A780-446D-8BEA-F28F226B7803Q48183224-643CCCB7-E884-4DC1-AB31-6E0ABC6AD5E4Q52807794-6C86AB52-5336-42E9-90A3-CCB82C84AA32Q53206937-EAA2BF63-E212-4AB2-BAE0-B33039005ABAQ55425790-1F512E78-10FD-4681-A086-DC5CD6510824Q58773826-2C70E06E-A903-4645-ACD6-F3E5867B201E
P2860
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
@en
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
@nl
type
label
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
@en
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
@nl
prefLabel
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
@en
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
@nl
P2093
P2860
P1476
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
@en
P2093
François-Pierre Mongeon
Otávio Rizzi Coelho-Filho
Raymond Y Kwong
Rodney H Falk
Ron Blankstein
P2860
P304
P356
10.1016/J.JCMG.2012.04.006
P577
2012-09-01T00:00:00Z